Thomas A Poole

US Patent:

20220354785, Nov 10, 2022

Filed:

Apr 19, 2022

Appl. No.:

17/724056

Inventors:

- London, GB
Nicholas Von Cosmos - Moravian Falls NC, US
Matthew Lampe - Winston-Salem NC, US
Steven Lee Alderman - Lewisville NC, US
Thomas H. Poole - Winston-Salem NC, US
Michael Andrew Zawadzki - Clemmons NC, US
Charlotte Smith - Winston-Salem NC, US

International Classification:

A61K 9/00
A61K 47/10
A61K 47/12
A61K 31/465

Abstract:

Products configured for oral use and methods for preparing such products are provided. In particular, such products may be provided in the form of a lozenge. In some embodiments, oral products described herein may include a first sugar substitute in an amount of at least about 80 weight percent, a basic amine, and an organic acid, an alkali metal salt of an organic acid, or a combination thereof. In one or more embodiments, at least a portion of the basic amine is associated with at least a portion of the organic acid or the alkali metal salt thereof, the association in the form of a basic amine-organic acid salt, an ion pair between the basic amine and a conjugate base of the organic acid, or both.

US Patent:

20220346434, Nov 3, 2022

Filed:

Apr 22, 2022

Appl. No.:

17/727154

Inventors:

- London, GB
Nicolas Von Cosmos - Moravian Falls NC, US
Matthew E. Lampe - Winston-Salem NC, US
Steven Lee Alderman - Lewisville NC, US
Thomas H. Poole - Winston-Salem NC, US

International Classification:

A24B 15/16
A61K 9/00
A61K 47/26
A61K 47/42
A61K 31/465
A61K 47/12
A61K 47/10
A24B 13/00
A24B 15/40
A24B 15/32
A24B 15/30
A23G 3/42
A23G 3/38
A23G 3/36
A23G 3/54

Abstract:

An oral product configured for oral use is provided herein, the oral product including: at least one sugar substitute in an amount from about 25% to about 45% by weight, based on the total weight of the oral product; a gum in an amount from about 35% to about 55% by weight, based on the total weight of the oral product; a basic amine; and an organic acid, an alkali metal salt of an organic acid, or a combination thereof; wherein the organic acid has a log P value of from about 1.0 to about 12.0; wherein at least a portion of the basic amine is associated with at least a portion of the organic acid or the alkali metal salt thereof, the association in the form of a basic amine-organic acid salt, an ion pair between the basic amine and a conjugate base of the organic acid, or both; and wherein the oral product is in the form of a pastille.